Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FIGS 
Figs Inc (FIGS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $6.42
1 Year Target Price $6.42
| 0 | Strong Buy |
| 1 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.87% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.18B USD | Price to earnings Ratio 144.4 | 1Y Target Price 6.42 |
Price to earnings Ratio 144.4 | 1Y Target Price 6.42 | ||
Volume (30-day avg) 10 | Beta 1.33 | 52 Weeks Range 3.56 - 7.74 | Updated Date 10/15/2025 |
52 Weeks Range 3.56 - 7.74 | Updated Date 10/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.26% | Operating Margin (TTM) 6.5% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) 1.8% |
Valuation
Trailing PE 144.4 | Forward PE 105.26 | Enterprise Value 1011280316 | Price to Sales(TTM) 2.07 |
Enterprise Value 1011280316 | Price to Sales(TTM) 2.07 | ||
Enterprise Value to Revenue 1.78 | Enterprise Value to EBITDA 53.63 | Shares Outstanding 154989563 | Shares Floating 149355796 |
Shares Outstanding 154989563 | Shares Floating 149355796 | ||
Percent Insiders 5.1 | Percent Institutions 93.98 |
Upturn AI SWOT
Figs Inc
Company Overview
History and Background
Figs Inc., founded in 2013, revolutionized the medical apparel industry by offering stylish, comfortable, and functional scrubs. It gained popularity through its direct-to-consumer model and focus on social media marketing.
Core Business Areas
- Apparel: Designs and sells medical apparel, primarily scrubs, but also including lab coats, under scrubs, outerwear, and compression socks.
- Lifestyle: Offers a range of lifestyle apparel and accessories designed for healthcare professionals outside of work hours.
Leadership and Structure
The leadership team includes Trina Spear (CEO) and Jeff York (Chairman). The company operates with a functional organizational structure, focusing on design, marketing, and operations.
Top Products and Market Share
Key Offerings
- Competitors: Med Couture, Healing Hands, Dickies Medical, Jaanuu
- Market Share (%): 6
- Scrubs: Figs' primary product is scrubs, known for their comfort and stylish designs. The market for scrubs is fragmented with many players. Figs has a significant portion of online sales, but overall market share is lower due to brick-and-mortar competition. Competitors include Med Couture, Healing Hands, and Dickies Medical.
- Competitors: Medline, Cardinal Health, Landau
- Lab Coats: Stylish lab coats offering the same features as their scrubs. No specific data available for lab coats alone. Competitors are traditional medical supply companies.
- Market Share (%): 0.5
Market Dynamics
Industry Overview
The medical apparel market is growing, driven by increasing healthcare employment and demand for comfortable, durable, and stylish uniforms. There's a shift towards direct-to-consumer brands and online sales.
Positioning
Figs is positioned as a premium, direct-to-consumer brand in the medical apparel market, emphasizing style, comfort, and community. Its competitive advantage lies in its brand image and customer loyalty.
Total Addressable Market (TAM)
The global medical apparel market is estimated to be worth billions of dollars. Figs is well-positioned to capture a growing share of this market through its innovative products and marketing strategies. TAM is estimated to be around $12B, growing at 4.5% annually. FIGS holds less than 7% of the TAM.
Upturn SWOT Analysis
Strengths
- Strong brand image and customer loyalty
- Direct-to-consumer model
- Innovative product designs
- Effective social media marketing
- Strong community building
Weaknesses
- Premium pricing may limit market reach
- Reliance on direct-to-consumer channel
- Vulnerable to copycat designs
Opportunities
- Expansion into new product categories (e.g., footwear)
- International market expansion
- Partnerships with healthcare organizations
- Development of sustainable and eco-friendly products
Threats
- Increased competition from established brands and new entrants
- Economic downturn affecting consumer spending
- Changes in healthcare regulations and policies
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- ADSCY
- DICK
- VSCP
Competitive Landscape
Figs' advantage is its strong brand and DTC model. Disadvantages include higher prices and potential vulnerability to larger competitors with more resources.
Growth Trajectory and Initiatives
Historical Growth: Figs experienced rapid growth in its early years, driven by its innovative products and marketing strategies.
Future Projections: Analyst projections vary. Consult latest filings and analyst reports for estimates.
Recent Initiatives: Figs has focused on expanding its product line and entering new markets. It continues to invest in marketing and brand building.
Summary
Figs is a relatively young company that has successfully disrupted the medical apparel market with its stylish and comfortable scrubs. Its strong brand and direct-to-consumer model have fueled rapid growth. However, Figs faces increasing competition and needs to maintain its innovative edge to sustain its growth trajectory. FIGS does not currently pay a dividend and depends upon stock appreciation.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Figs Inc. Investor Relations, Third-party market research reports, Analyst reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange NYSE | Headquaters Santa Monica, CA, United States | ||
IPO Launch date 2021-05-27 | Co-Founder, CEO & Director Ms. Catherine Eva Spear | ||
Sector Consumer Cyclical | Industry Apparel Manufacturing | Full time employees 303 | Website https://www.wearfigs.com |
Full time employees 303 | Website https://www.wearfigs.com | ||
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.